Psychiatr. pro Praxi, 2001; 1: 33-34

Nově registrovaná psychofarmaka ovlivňující vigilitu

doc. MUDr. Karel ©onka CSc
Centrum pro poruchy spánku a bdění, Neurologická klinika 1. LF UK a VFN, Praha

Published: December 31, 2001  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
©onka K. Nově registrovaná psychofarmaka ovlivňující vigilitu. Psychiatr. praxi. 2001;2(1):33-34.

Centrum pro poruchy spánku a bdění neurologické kliniky

Univerzita Karlova v Praze, I. lékařská fakulta a Vąeobecná fakultní nemocnice, Praha

Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Billiard M, Besset A, Montplaisir J, Laffont F, Goldenberg F, Weill JS, Lubin S. Modafinil: a double-blind multicentric study. Sleep, 1994; 17: S107-S112. Go to original source... Go to PubMed...
    2. Broughton RJ, Fleming JAE, George CFP, Hill JD, Kryger MH, Moldofsky H, Montplaisir JY, Morehouse RL, Moscovitch A, Murphy WF. Randomised, double blind, placebo-controlled crossover trial of modafinil in the treatment of excessive daytime sleepiness in narcolepsy. Neurology, 1997; 49: 444-451. Go to original source... Go to PubMed...
    3. Carlander B. Traitments de la narcolépsie et autres troubles primaires de l´éveil. In: Le sommeil normal et pathologique. Troubles du sommeil et de l´éveil. Ed. by M Billiard. Masson, Paris, 1998: 306-313.
    4. Chemelli RM, Willie JT, Sinton CM, Eimquist JK, Scammell T, Lee C, Richardson JA. Narcolepsy in orexin knockout mice: Molecular genetics of sleep regulation. Cell, 1999; 98: 437-451. Go to original source... Go to PubMed...
    5. Lin JS, Hou Y, Jouvet M. Potential brain neuronal targets for amphetamine, methylphenidate and modafinil-induced wakefulness evidenced by c-fos immunocytochemistry in the cat. Prot Natl Acad Sci USA, 1996; 93: 1428-1433. Go to original source... Go to PubMed...
    6. Moachon G, Kanmacher I, Clenet M. Pharmacokinetic profile of modafinil. Drugs Today, 1996; 32 (suppl. 1): 23-33.
    7. Nevąímalová S, ©onka K. Poruchy spánku a bdění. Maxdorf Jessenius, Praha, 1997: 1-255.
    8. Saletu B, Frey R, Krupka M, Anderer P, Grümberger J, Barbanoj MJ. Differential effects of a new central adrenergic agonist - modafinil - and d-amfetamine on sleep and early morning behaviour in young healthy volunteers. Int J Clin Pharm Res, 1989; 9: 183-195.
    9. ©onka K. Dyssomnie a jejich léčení. Remedia, 1998, 8: 93-99.
    10. US Modafinil in Narcolepsy Multicenter Study Group. Randomized Trial of Modafinil for the Treatment of Pathological Somnolence in Narcolepsy. Ann of Neurol, 1998; 43: 88-97. Go to original source... Go to PubMed...
    11. Dooley M, Plosker GL. Zaleplon - a review of its use in the treatment of insomnia. Drugs, 2000; 60: 413-445. Go to original source... Go to PubMed...
    12. Fry J, Scharf M, Mangano R, Fujimori M. Zaleplon improves sleep without producing rebond effects in outpatients with insomnia. Internat clin psychopharmacol, 2000;15:141-152. Go to original source... Go to PubMed...
    13. Elie R, Ruther E, Farr I, Emilien G, Salinas E. Sleep latency is shortened during 4 weeks of treatment with zaleplon a novel nonbenzodiazepine hypnotic. J Clin Psych, 1999; 60: 536-544. Go to original source... Go to PubMed...
    14. Heydorn WE. Zaleplon - a review of a novel sedative hypnotic used in the treatment of insomnia. Expert opinion on investigational drugs, 2000; 9: 841-858. Go to original source... Go to PubMed...
    15. Troy SM, Lucki I, Untuh MA, Cevallos WH, Leister CA, Martin PT, Furland PMB. Mandgano R. Comparison of the effects of zaleplon, zolpidem, and triazolam on memory, learning, and psychomotor performance. J Clin Psychopharmacol, 2000; 20: 328-337. Go to original source... Go to PubMed...
    16. Vermeeren A, Danjou PE, O´Hanlon JF. Residual effects of evening and middle-of-the-night administration of zaleplon 10 and 20 mg on memory and actual driving performance. Hum Psychopharmacol Clin Exp, 1998; 13: S98-S107. Go to original source...

    Return to the content


    Psychiatry for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.